EUVIMEDEUVIMED entdecken
Crossref

IBRUTINIB VERSUS PLACEBO IN PATIENTS WITH ASYMPTOMATIC, TREATMENT‐NAïVE EARLY STAGE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): FINAL RESULTS OF THE CLL12 TRIAL

P. Langerbeins, S. Robrecht, P. Nieper, P. Cramer, M. Fürstenau, O. Al‐Sawaf, A. Fink, K. Kreuzer, U. Vehling‐Kaiser, E. Tausch, C. Schneider, L. Müller und 23 weitere

Hematological Oncology · 2023-06 · 41 (S2) · 56-58

DOI: 10.1002/hon.3163_24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hematological Oncology, online erschienen am 09.06.2023. Verfasst von P. Langerbeins und 34 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Langerbeins, P., Robrecht, S., Nieper, P., Cramer, P., Fürstenau, M., Al‐Sawaf, O., Fink, A., Kreuzer, K., Vehling‐Kaiser, U., Tausch, E., Schneider, C., Müller, L., Schlag, R., Freier, W., Gaska, T., Balser, C., Reiser, M., Stauch, M., Zahn, M., …, & Hallek, M. (2023). IBRUTINIB VERSUS PLACEBO IN PATIENTS WITH ASYMPTOMATIC, TREATMENT‐NAïVE EARLY STAGE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): FINAL RESULTS OF THE CLL12 TRIAL. Hematological Oncology, 41(S2), 56-58. https://doi.org/10.1002/hon.3163_24

Vancouver

Langerbeins P, Robrecht S, Nieper P, Cramer P, Fürstenau M, Al‐Sawaf O, et al. IBRUTINIB VERSUS PLACEBO IN PATIENTS WITH ASYMPTOMATIC, TREATMENT‐NAïVE EARLY STAGE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): FINAL RESULTS OF THE CLL12 TRIAL. Hematological Oncology. 2023;41(S2):56-58. doi:10.1002/hon.3163_24

BibTeX
@article{Langerbeins2023,
  author = {Langerbeins, P. and Robrecht, S. and Nieper, P. and Cramer, P. and Fürstenau, M. and Al‐Sawaf, O. and Fink, A. and Kreuzer, K. and Vehling‐Kaiser, U. and Tausch, E. and Schneider, C. and Müller, L. and Schlag, R. and Freier, W. and Gaska, T. and Balser, C. and Reiser, M. and Stauch, M. and Zahn, M. and Dörfel, S. and Eckart, M. J. and Staib, P. and Behlendorf, T. and Hensel, M. and Hebarth, H. and Klaproth, H. and Block, A. and Liersch, R. and Hauch, U. and Heinrich, B. and Wendtner, C. and Fischer, K. and Stilgenbauer, S. and Eichhorst, B. and Hallek, M.},
  title = {IBRUTINIB VERSUS PLACEBO IN PATIENTS WITH ASYMPTOMATIC, TREATMENT‐NAïVE EARLY STAGE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): FINAL RESULTS OF THE CLL12 TRIAL},
  journal = {Hematological Oncology},
  year = {2023},
  volume = {41},
  number = {S2},
  pages = {56--58},
  doi = {10.1002/hon.3163_24}
}
Kostenlos starten →